Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Kelly A Gebo, associate professor of medicine, epidemiology
  1. 1Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
  1. kgebo{at}jhmi.edu

    Increased longevity as a result of HAART raises new questions about the best treatment

    The median age of people living with HIV in the developed world is increasing because of improved longevity from highly active antiretroviral therapy (HAART) and an increase in new HIV infections in older people.1 The prevalence of HIV in older people will continue to increase over the next decade, and around 50% of people living with HIV will be older than 50 by 2015.2 Although 50 years is not a common threshold for advanced age, early in the HIV epidemic the Centres for Disease Control and Infection identified HIV infected patients aged 50 or more as a separate group because the mean age of infected people was then much lower than 50.

    In the early days of the HIV epidemic older patients had higher morbidity, higher mortality, and a shorter AIDS free survival than younger people with HIV. …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    Read related article

    See previous polls

    BMJ most popular